Latest News in the pharma Industry

Policy & Regulation

FDA Approves KALYDECO (Ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis

FDA Approves KALYDECO (Ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis

25 Feb 2014

Read more 
A&C American Chemicals Received EXCiPACT Certification as Pharmaceutical Excipient Supplier

A&C American Chemicals Received EXCiPACT Certification as Pharmaceutical Excipient Supplier

21 Feb 2014

Read more 
FDA Initiates the Secure Supply Chain Pilot Programme to Enhance Security of Imported Drugs

FDA Initiates the Secure Supply Chain Pilot Programme to Enhance Security of Imported Drugs

20 Feb 2014

Read more 
FDA and European Medicines Agency Strengthen Collaboration in Pharmacovigilance Area

FDA and European Medicines Agency Strengthen Collaboration in Pharmacovigilance Area

20 Feb 2014

Read more 
Selvita Group Receives GMP Certificate

Selvita Group Receives GMP Certificate

19 Feb 2014

Read more 
Transport Validation: New Considerations by Annex 15

Transport Validation: New Considerations by Annex 15

19 Feb 2014

Read more 
FDA Grants Accelerated Approval to ibrutinib for the Treatment of Patients with CLL

FDA Grants Accelerated Approval to ibrutinib for the Treatment of Patients with CLL

14 Feb 2014

Read more 
EU Q&A on Importation of APIs

EU Q&A on Importation of APIs

6 Feb 2014

Read more 
New FDA Guidance for Drug Development Tools

New FDA Guidance for Drug Development Tools

4 Feb 2014

Read more 
Eli Lilly and Company Provides Statement in Response to Sanofi US Lawsuit

Eli Lilly and Company Provides Statement in Response to Sanofi US Lawsuit

3 Feb 2014

Read more 
Merck Statement on FDA Advisory Committee Meeting for RAGWITEK, an Investigational Sublingual Allergy Immunotherapy Tablet

Merck Statement on FDA Advisory Committee Meeting for RAGWITEK, an Investigational Sublingual Allergy Immunotherapy Tablet

29 Jan 2014

Read more 
Novartis to Request Re-Examination of Serelaxin in Acute Heart Failure for Conditional Marketing Authorisation in EU

Novartis to Request Re-Examination of Serelaxin in Acute Heart Failure for Conditional Marketing Authorisation in EU

27 Jan 2014

Read more